Saurav Chemicals Limited has officially received the Eudra GMP Certification from the French National Agency for the safety of Medicine and Health Products (ANSM)        |        Saurav Chemicals Limited has received official approval from the European Directorate for the Quality of Medicines & HealthCare (EDQM) for Clopidogrel Hydrogen Sulfate

About SCL

Our aim is to be a reliable supplier and CDMO services provider for pharmaceutical intermediates and APIs

SCL was incorporated on December 20, 1993, as a Private Limited Company. Initially, it manufactured intermediates. On July 1, 1997, the company became a Public Limited Company and adopted its current name. In 2004, SCL established a new API manufacturing facility. Today, it offers a wide range of APIs and advanced intermediates in various therapeutic segments such as NSAIDs, cardiology, anti-cholinergic, CNS, anti-filarials, and anthelmintics, among others, to its customers. We are based in Panchkula, near Chandigarh, with two manufacturing facilities in Derabassi, Mohali (Punjab), for intermediates and APIs. The marketing office is located in Delhi NCR. We have acquired 22 acres of land for expanding facilities near the current site.

aboutus
SCL caters to both the domestic and international markets, with approximately 60% of the total revenue coming from the international market.
  • • We are engaged in manufacturing bulk drugs/APIs and advanced intermediates.
  • • We also specialize in providing CDMO services to clients in regulated markets in Europe, the USA, and Japan.
SCL has expanded its global presence over the years, with key export markets including: Europe (France, Spain, Germany, Italy, Greece, Austria, Portugal, Slovenia, Netherlands, Denmark), the United States of America (USA), Turkey, Japan, Korea, Brazil, Russia & CIS countries, South & Central America, the Middle East & Northern Africa (MENA) region, and other Asian countries.
Our manufacturing facilities comply with the following regulatory standards:
  • • United States Food and Drug Administration (USFDA)
  • • European Union Good Manufacturing Practices (EU-GMP)
  • • Therapeutic Goods Administration (TGA) Australia
  • • Ministry of Food and Drug Safety (MFDS) Korea
  • • Japanese Pharmaceutical and Medical Devices Agency (JPMDA)
SCL caters to both the Domestic as well as the International Market. It derived ~60% of the total revenue from the International market and the remaining ~40% from the Domestic market. SCL is engaged in manufacturing Bulk Drugs/Active Pharmaceutical Ingredients (APIs) and Advanced Intermediates. We provide CDMO Services to our clients in regulated markets of Europe, USA and Japan.

SCL has over the years expanded its presence across the globe with key export markets being Europe (France, Spain, Germany, Italy, Greece, Austria, Portugal, Slovenia, Netherlands, Denmark), the United States of America (USA), Turkey, Japan, Korea, Brazil, Russia & CIS countries, South & Central America, Middle East & Northern Africa (MENA) region & other Asian countries.

The Company is headquartered at Panchkula (Haryana) near Chandigarh and has 2 Manufacturing facilities (one each for intermediates & APIs) located at Derabassi, Mohali (Punjab). Marketing office for the company is based out of Delhi NCR. Company has acquired 22acres of land for adding facilities near the existing site.

The Manufacturing facilities of the Company comply with the United States Food and Drug Administration (USFDA), European Union Good Manufacturing Practices (EU-GMP), TGA Australia, MFDS Korea  & Japanese Pharmaceutical and Medical Devices Agency (JPMDA).

Our Growth Story

Start

2002

Becomes largest supplier of Cephalosporin & Penem Intermediates in India

2013

Joint Venture with Mitsubishi Corporation, Japan

2014

SCL receives WHO Geneva GMP approval

16-18

USFDA Approval in March '16, '17, '18. WHO GENEVA Empanelment KFDA, First CEP received, Purchase of New Greenfield Site

2022

SCL ventured into development of Vaccine Ingredients, with proposed pipeline of 25 products

1990

First manufacturing facility (for Intermediates) set up in late 90's

04-08

API manufacturing site set up First EU GMP Certificaton of API site in 2005, Subsequent approvals in, 2008, 2011, 2012 & 2015

2015

AFM registration with PMDA, Japan EU GMP by Danish Medicine, TGA Empanelment


19-21

Second CEP, TGA Empanelment, PMDA approval

2024

SCL sets up a Knowledge Centre at the Genome Valley in Hyderabad, EDQM certification received
History

Our Core Values

Respectful of Compliance

We value compliance as the core of our business. Understanding and managing its complexities, we ensure compliance at every step, upholding its importance.

True Partners to Our Customers

We forge valuable, lasting relationships. Together, we ensure success, going the extra mile with trust and reliability.

Commitment to Quality

Your journey to world-class products begins with us. Quality is our way of life.

Transparent Working

Trust is the foundation of great partnerships. By fostering clarity, we ensure reliability and establish expectations you can count on.

Creating Cost-Effective Solutions

Our result-oriented approach ensures exceptional customer satisfaction and helps you build a successful business.

Focus on Results

A focused, result-oriented approach is our key to exceptional customer satisfaction. Our way of helping you build your successful business.

Our Mission & Vision

Efficacy and purity of products to enhance the quality of human life
Complete compliance with international standards of health and environment
Committed to the cause of planet and people
Harnessing India’s knowledge and skills for alleviating human suffering
To be an internationally recognized supplier of APIs and pharmaceutical intermediates to the regulated markets
To offer CMO services for the regulated markets

Know more about SCL Vision & Mission

Our Vision Our Mission
  • Delivering Value to life to Health
  • Efficacy and Purity of products to enhance quality of human life
  • Complete compliance to the international standards of Health & Environment

  • Committed to cause of Planet & People
  • Harnessing India’s knowledge skills for alleviating human suffering.

  • To be an Internationally recognized supplier of APIs and Pharmaceutical Intermediates to the regulated Markets.

  • To offer CMO Services for the regulated markets.

  • Delivering Value to life to Health
  • Efficacy and Purity of products to enhance quality of human life
  • Complete compliance to the international standards of Health & Environment
  • Committed to cause of Planet & People
  • Harnessing India’s knowledge skills for alleviating human suffering.
  • To be an Internationally recognized supplier of APIs and Pharmaceutical Intermediates to the regulated Markets.
  • To offer CMO Services for the regulated markets.

Get In Touch